where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

cancer Published date June 24, 2024 Abstract "Pancreatic ductal adenocarcinoma (PDAC) remains a dreadful disease

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb

where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease

prenylation contributes to multiple disorders, including cancers and vascular and neurodegenerative diseases

Published date November 3, 2023 Abstract " Purpose: Peripheral T-cell lymphoma (PTCL) is an aggressive disease

Published date November 1, 2022 Abstract Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive disease

primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear understanding of disease

indicated that beclomethasone dipropionate (BDP), an agonist of GPR97, attenuated the psoriasis-like skin disease

Ram, Gauri Ganesh, Misun Kang, Sunita Ho, Edward C Hsiao Tags Wnt pathway inhibition , fibrotic bone disease

there was not much known other than that they are huge and somehow play important roles in health and disease

Patients with ERα-positive/PR-negative tumors have shorter disease-free and overall survival than patients

cellular mechanisms by which mutations in a chloride-proton antiporter cause the renal disorder Dent’s disease

research focuses on investigating GPCR signaling and trafficking in the context of inflammation and chronic

Published date December 8, 2023 Abstract " Background: Acute respiratory distress syndrome (ARDS) is a disease

"Background: Neuroinflammation is a widely studied phenomenon underlying various neurodegenerative diseases

Genetic variants in RGS proteins are associated with many diseases, including cancers, although the impact

0.55-0.92; P = 0.009), progression free interval (PFS) (HR: 1.776; 95% CI: 1.067-2.955; P = 0.001) and disease

then moved to King's College London, where my interest and passion for kinases in brain health and disease

which causes loss of sensory and motor function in the body below the level of injury, is a devastating disease

novel human genetic variants identified in several GPCRs associated with obesity and other metabolic diseases